Artelo Biosciences ARTL
NASDAQ ARTL
$3.68 -0.15 (-3.92%)
At close: Oct 2, 2026 · 4:00 PM EDT

Artelo Biosciences (ARTL) Non Operating Investment Income (2021 - 2024)

Updated

Artelo Biosciences (ARTL) recorded Non Operating Investment Income of $22,000 in FY2025.

Analysis

Artelo Biosciences (ARTL) Non Operating Investment Income (2021 - 2024) Analysis & Trends

  • Annual Non Operating Investment Income has a three-year compound annual growth rate of -52.6% (FY2022 to FY2025).
  • Per Business Quant data, ARTL's Non Operating Investment Income was $641,000 in FY2023 (+209.7%) and $207,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Artelo Biosciences 73,320.32 -5.06 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -248,000.00
Sep 30, 2024 63,000.00
Jun 30, 2024 79,000.00
Mar 31, 2024 106,000.00
Dec 31, 2023 167,000.00
Sep 30, 2023 165,000.00
Jun 30, 2023 185,000.00
Mar 31, 2023 124,000.00
Dec 31, 2022 137,000.00
Sep 30, 2022 69,000.00
May 31, 2021 984.00
Feb 28, 2021 1,335.00
API Access

Artelo Biosciences Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=ARTL&period=max&api_key=YOUR_API_KEY